Medexus Pharmaceuticals Inc. (OTCMKTS:MEDXF – Get Rating)’s stock price was up 2.5% during trading on Monday . The stock traded as high as $0.93 and last traded at $0.93. Approximately 10,000 shares were traded during mid-day trading, a decline of 27% from the average daily volume of 13,728 shares. The stock had previously closed at $0.91.
Analysts Set New Price Targets
Several equities research analysts have recently issued reports on MEDXF shares. Raymond James raised their price target on shares of Medexus Pharmaceuticals from C$3.50 to C$4.00 in a research note on Friday, March 10th. Stifel Nicolaus lowered shares of Medexus Pharmaceuticals from a “buy” rating to a “hold” rating in a research note on Thursday, February 9th.
Medexus Pharmaceuticals Stock Performance
The company’s 50 day moving average price is $1.04 and its 200-day moving average price is $1.29.
About Medexus Pharmaceuticals
Medexus Pharmaceuticals, Inc operates as a pharmaceutical company, which provides healthcare products to Healthcare Professionals and patients and focuses on therapeutic areas of auto-immune disease and pediatrics. The firm products include Rasuvo, Ixinity and Triamcinolone Hexacetonide. The company was founded by Sylvain Chretien in January 2008 and is headquartered in Bolton, Canada.
- Get a free copy of the StockNews.com research report on Medexus Pharmaceuticals (MEDXF)
- monday.com Surges on Price and Volume after Blowout Results
- Can Ryanair Stock Fly Above Resistance Levels, What Earnings Show
- All Aboard! The Sell-Side Has Railroads In Reversal
- Is There Value Left in Lyft Stock?
- Everything About ZIM Integrated Screams Undervaluation
Receive News & Ratings for Medexus Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Medexus Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.